Cresco Labs Inc. — News

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended June 30th, 2026 on Thursday, August 6, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with ke.

businesswire.com - 2026-07-13 06:30:00

The cannabis industry continues evolving as operators focus on profitability, stronger balance sheets, and strategic expansion. At the same time, federal cannabis reform discussions have improved investor sentiment. Many companies are also positioning themselves for future regulatory changes. As a result, investors are paying closer attention to established multi-state operators with recognizable brands and expanding retail footprints.

marijuanastocks.com - 2026-06-30 10:00:44

The cannabis industry continues to evolve across the United States. Several operators are expanding their retail footprints while improving profitability. At the same time, investors are watching for regulatory changes that could support future growth. As a result, leading multi-state operators remain popular among cannabis-focused investors.

marijuanastocks.com - 2026-06-16 10:00:39

CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.

zacks.com - 2026-06-11 09:16:04

CHICAGO--(BUSINESS WIRE)--Access to commercial bank financing enhances financial flexibility and supports Cresco Labs' disciplined growth and consolidation strategy.

businesswire.com - 2026-06-08 06:00:00

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances.

businesswire.com - 2026-05-27 06:30:00

Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com - 2026-05-11 13:01:18

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) has announced a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced.

businesswire.com - 2026-05-11 06:30:00

Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-08 12:31:23

Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.04 per share a year ago.

zacks.com - 2026-05-08 09:05:48

CHICAGO--(BUSINESS WIRE)--Cresco Labs Reports First Quarter 2026 Financial Results.

businesswire.com - 2026-05-08 06:30:00

Cresco Labs Inc. (CRLBF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

zacks.com - 2026-05-06 09:55:57

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Aberdeen, located in Aberdeen, Ohio. This marks the Company's second Ohio dispensary opening in the past month, increasing its footprint to eight locations statewide and 74 nationally. “Sunnyside Aberdeen is our second dispensary opening in the state in a month, reflecting our commitment to serving more communities across Ohio,” said Cha.

businesswire.com - 2026-05-05 06:30:00

The cannabis industry in the United States is entering a new phase of sustained growth, positioning itself as one of the most closely watched emerging sectors for both investors and industry professionals. As legalization continues to expand at the state level, the legal framework supporting the cannabis industry is becoming stronger and more normalized. With only a handful of states yet to adopt full medical or adult-use programs, cannabis is approaching near-national acceptance, significantly increasing the total addressable market.

marijuanastocks.com - 2026-05-04 13:20:04

The cannabis industry has become one of the most closely watched emerging sectors in global finance. As a result, marijuana stocks are attracting growing attention from both retail and institutional investors. Once viewed as speculative, the sector is now evolving into a more structured market. Currently, it is driven by stronger fundamentals, regulatory progress, and long-term consumer demand. As legalization expands and capital markets begin to open, the investment case for top marijuana stocks to buy is becoming more compelling. A major catalyst reshaping cannabis stocks has been the U.S. government's move toward rescheduling cannabis.

marijuanastocks.com - 2026-04-29 12:04:11

On the heels of the executive order to fast-track research into psychedelic drugs, a second major federal policy shift on April 23, 2026, is sending waves through the cannabis sector. However, the real catalyst is being widely misunderstood by many on Wall Street.

marketbeat.com - 2026-04-23 14:40:26

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell in response to the Department of Justice's final rule publication rescheduling medical cannabis from Schedule I to Schedule III under the Controlled Substances Act. “Rescheduling medical cannabis is a long-overdue step that finally brings federal policy closer to the science. For the first time in history, our fed.

businesswire.com - 2026-04-23 13:24:00

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended March 31st, 2026 on Friday, May 8, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key bu.

businesswire.com - 2026-04-23 06:30:00